What is the recommended daily fluid intake for an adult patient with chronic kidney disease stage 4 (eGFR 15–29 mL/min/1.73 m²) without overt fluid overload?

Recommended Fluid Intake in CKD Stage 4 Patients

For CKD stage 4 patients (eGFR 15-29 mL/min/1.73 m²) without fluid overload, aim for approximately 1.0-1.5 liters per day of plain water intake, with total fluid intake individualized based on urine output, volume status, and comorbidities—avoiding both extremes of very low (<0.5 L/day) and very high (>2.0 L/day) plain water consumption.

Evidence-Based Rationale

The KDIGO 2024 guidelines do not provide specific fluid intake recommendations for CKD stage 4 patients, so we must rely on research evidence to guide practice. The most relevant and recent study addressing this question is the CKD-REIN cohort 1, which examined 1,265 CKD patients with mean eGFR of 32 mL/min/1.73 m² over 6 years.

Key Findings from CKD-REIN Study

The CKD-REIN cohort 1 demonstrated a U-shaped relationship between plain water intake and kidney failure risk:

• Lowest risk group: 1.0-1.5 L/day of plain water (reference group)
• Increased risk with low intake: <0.5 L/day showed HR 1.88 (95% CI: 1.02-3.47)
• Increased risk with moderate-low intake: 0.5-1.0 L/day showed HR 1.59 (95% CI: 1.06-2.38)
• Increased risk with high intake: 1.5-2.0 L/day showed HR 1.76 (95% CI: 0.95-3.24)
• Increased risk with very high intake: >2.0 L/day showed HR 1.55 (95% CI: 1.03-2.32)

This U-shaped curve is critical: both insufficient and excessive plain water intake accelerate CKD progression.

Physiological Considerations

The study also found that kidney failure risk increased significantly with urine osmolality <292 mosm/L 1, suggesting that excessive dilution of urine may be harmful. This contradicts older hypotheses that higher water intake universally benefits kidney function.

Clinical Algorithm for Fluid Management

Step 1: Assess Baseline Status

• Check for volume overload: edema, weight gain, hypertension, jugular venous distension
• Measure 24-hour urine volume if possible (target: 1.5-2.0 L/day)
• Review medications: diuretics, SGLT2 inhibitors (which increase urine output)

Step 2: Set Fluid Targets

• If no volume overload and normal urine output: Recommend 1.0-1.5 L/day plain water
• Total fluid intake (including food moisture, other beverages): approximately 2.0 L/day
• If on diuretics: May need slightly higher intake to compensate for losses
• If on SGLT2 inhibitors: Monitor for volume depletion; may need adequate hydration

Step 3: Monitor Response

• Monthly weight checks for volume status
• Serum sodium: Should remain stable (135-145 mEq/L)
• Blood pressure trends: Avoid both volume overload and depletion
• eGFR trajectory: Excessive fluid restriction or overload both accelerate decline

Important Caveats and Pitfalls

Common Pitfalls to Avoid

1. Avoid the "drink more water" reflex: The older pilot study 2 suggested benefit from increased water intake, but the larger, more definitive CKD-REIN cohort 1 showed harm from excessive intake in established CKD. The U-shaped curve means more is not better.

2. Don't extrapolate from general population guidelines: Standard recommendations of 2.0-2.5 L/day for healthy adults 3 may be excessive for CKD stage 4 patients.

3. Distinguish plain water from total fluid intake: The CKD-REIN study 1 found that plain water intake specifically showed the U-shaped relationship, while total water intake did not show the same association. This suggests the type of fluid matters.

4. Consider medication effects: SGLT2 inhibitors (recommended for CKD stage 4 with eGFR ≥20 mL/min/1.73 m²) 4 cause osmotic diuresis and may require adjustment of fluid recommendations.

Special Circumstances

• Heart failure comorbidity: Stricter fluid restriction may be needed (typically 1.5-2.0 L total daily fluid)
• Residual urine output: If oliguria develops, further restrict fluids to match output plus insensible losses (approximately 500 mL)
• Hot climate or physical labor: May require individualized increases to prevent dehydration
• Hyponatremia: Suggests excessive free water intake; restrict further

Strength of Evidence

The CKD-REIN cohort 1 from 2022 represents the highest quality evidence available, with 1,265 patients followed prospectively with detailed fluid intake assessments and hard outcomes (kidney failure, eGFR decline). This supersedes earlier smaller studies 2, 5 that suggested benefit from increased water intake, as those studies had shorter follow-up and smaller sample sizes.

The absence of specific fluid recommendations in KDIGO 2024 guidelines 4 reflects the complexity and lack of consensus in this area, making the CKD-REIN data particularly valuable for clinical decision-making.